I/D ACE gene polymorphism in survival of leukemia patients – hypothesis and pilot study

An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels.

Brigitte Rigat, C. Hübert, F Alhenc‐Gelas et al. · Journal of Clinical Investigation · 1990 · 3.8K citations · Full text

Life Sciences, Genetics, Molecular Genetics +13

PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1)

Brigitte Rigat, Christine Hübert, Pierre Corvol et al. · Nucleic Acids Research · 1992 · 1.3K citations · Full text

Life Sciences, Genetics, Molecular Genetics +11

Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer?

Anthony F. Lever, David Hole, C. Gillis et al. · The Lancet · 1998 · 547 citations

Medicine, Oncology, Pharmacology +8

Guidelines for clinical protocols for chronic lymphocytic leukemia: Recommendations of the national cancer institute‐sponsored working group

Bruce D. Cheson, John M. Bennett, Michael R. Grever et al. · American Journal of Hematology · 1988 · 407 citations

Medicine, Hematology, Immunology +16

Angiotensin-converting-enzyme gene insertion/deletion polymorphism and response to physical training

Hugh Montgomery, Peter Clarkson, Maria Barnard et al. · The Lancet · 1999 · 241 citations

Life Sciences, Genetics, Molecular Genetics +14